Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population by Li, XM et al.
Title Evidence for genetic association of TBX21 and IFNG withsystemic lupus erythematosus in a Chinese Han population
Author(s) Leng, RX; Pan, HF; Liu, J; Yang, XK; Zhang, C; Tao, SS; Wang,DG; Li, XM; Li, XP; Yang, W; Ye, DQ
Citation Scientific Reports, 2016, v. 6, p. 22081
Issued Date 2016
URL http://hdl.handle.net/10722/226378
Rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1Scientific RepoRts | 6:22081 | DOI: 10.1038/srep22081
www.nature.com/scientificreports
Evidence for genetic association 
of TBX21 and IFNG with systemic 
lupus erythematosus in a Chinese 
Han population
Rui-Xue Leng1,2, Hai-Feng Pan1,2, Juan Liu1,2, Xiao-Ke Yang1,2, Chao Zhang1,2, Sha-Sha Tao1,2,  
De-Guang Wang3, Xiao-Mei Li4, Xiang-Pei Li4, Wanling Yang5 & Dong-Qing Ye1,2
TBX21 recode T-bet which is an important transcription factor that drives the Th1 immune response 
primarily by promoting expression of the interferon-gamma (IFNG) gene. Recent studies have shown 
that genetic variants in TBX21 and IFNG are connected with risk of systemic lupus erythematosus 
(SLE). The aim of the present study was to replicate these genetic associations with SLE in Anhui 
Chinese population. Genotyping of 3 variants (rs4794067 in TBX21, rs2069705 and rs2069718 in IFNG) 
was performed. A total of 3732 subjects were included in the final analysis. The study only identified 
the association of rs2069705 with SLE susceptibility (T vs. C: odds ratio [OR] = 1.12, 95% confidence 
interval [CI] = 1.00–1.26, P = 0.046). Combined analysis with Hong Kong GWAS showed that the OR for 
rs2069705 was 1.10 (95% CI: 1.01–1.21, P = 0.027). Further pooled analysis with Korean populations 
involving 10498 subjects showed a more significant association between rs2069705 and SLE (T vs. C: 
OR = 1.11, 95%CI = 1.04–1.19, P = 0.002; TT + TC vs. CC: OR = 1.11, 95%CI = 1.02–1.21, P = 0.012; TT vs. 
TC + CC: OR = 1.28, 95%CI = 1.07–1.54, P = 0.008; TT vs. CC: OR = 1.33, 95%CI = 1.10–1.60, P = 0.003). 
In addition, we also identified a significant genetic interaction between rs2069705 and rs4794067 in 
Anhui Chinese population. Our study suggests that IFNG and IFNG-TBX21 interaction are involved in 
SLE susceptibility.
Systemic lupus erythematosus (SLE) is a prototypic, systemic, autoimmune disease, characterized by autoan-
tibody production and systemic inflammation. Numerous studies have proved that there was a strong genetic 
susceptibility and a multifactorial aetiology underlying SLE, in which gene–gene interactions may jointly affect 
the onset of the disease1–3.
The transcription factor T-bet (TBX21) is the master regulator of Th1 cell fate primarily by promoting expres-
sion of the interferon-gamma (IFNG) gene. IFNG is a type II interferon playing diverse roles in innate and adap-
tive immune systems. Elevated expression of IFNG has been found in peripheral blood T cells of SLE patients4. 
Furthermore, in murine models of lupus, deletion of Ifng leads to an improvement of lupus-like symptoms5. 
Available data has shown that TBX21 polymorphisms are associated with risk of several autoimmune diseases 
including rheumatoid arthritis (RA)6 and systemic sclerosis (SSc)7. It has been demonstrated that the C allele of 
rs4794067 in the TBX21 promoter is associated with a significant decrease in T-bet and IFNG production by stim-
ulated human lymphocytes from healthy individuals8,9. A previous study reported that the frequency of C allele 
of rs4794067 was significantly lower in SLE patients than in controls in Chongqing Chinese Han population. It 
should be noted that the cohort in this study were too small (only 248 cases and 261 controls were included) to 
have enough power to detect real association10. Previous study also reported that several IFNG polymorphisms 
were associated with susceptibility to SLE in unrelated Korean subjects11,12. However, no replication study has 
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evaluated for this relationship of IFNG in other ancestries. It is also unknown whether there is a genetic interac-
tion between TBX21 and IFNG given their functional association. We therefore investigated possible associations 
between above genes and SLE in a Chinese Han population with relatively larger samples (3732 subjects).
Results
Polymorphisms in IFNG and TBX21 with SLE risk. A total of 3732 subjects (1466 SLE patients and 2266 
controls) were included in the final analysis. The mean ± SD age of patients with SLE was 36.2 ± 12.7 years, and 
91.5% were women. The mean ± SD age of the control subjects was 36.9 ± 14.7 years, and 84.5% were women. No 
single-nucleotide polymorphism (SNP) deviated from HWE (P ≥ 0.506). The result of association for each SNP is 
shown in Table 1. In this study, we only identified that the T allele of rs2069705 in IFNG promoter was marginally 
associated with SLE susceptibility in Anhui Chinese Han population (T vs. C: odds ratio [OR] = 1.12, 95% confi-
dence interval [CI] = 1.00–1.26, P = 0.046), but did not survive bonferroni correction. Meanwhile, only a similar 
trend for rs2069705 was observed in Hong Kong genome-wide association studies (GWAS) (T vs. C: OR = 1.08, 
95% CI: 0.94–1.24). The pooled OR for rs2069705 in the two Chinese populations (including 2072 cases and 
4432 controls) was 1.10 (95% CI: 1.01–1.21, P = 0.027) (Table 2). Given the similar association of rs2069705 with 
SLE observed in Korean populations, we carried out a meta-analysis of all cases and controls (a total of 10498 
subjects including 3599 patients with SLE and 6899 healthy controls) to maximize the number of samples for the 
association analysis. The combined analysis showed a significant association between rs2069705 and SLE (T vs. 
C: OR = 1.11, 95%CI = 1.04–1.19, P = 0.002; TT + TC vs. CC: OR = 1.11, 95%CI = 1.02–1.21, P = 0.012; TT vs. 
TC + CC: OR = 1.28, 95%CI = 1.07–1.54, P = 0.008; TT vs. CC: OR = 1.33, 95%CI = 1.10–1.60, P = 0.003). We 
further performed subgroup analysis according to ethnicity (Chinese or Korean) and genotyping method. The 
data showed a significant and consistent trend toward increased risk of SLE in different subgroups (Table 2). In 
contrast with previous studies, significant association with SLE susceptibility was not observed for rs4794067 (C 
vs. T: P = 0.647) and rs2069718 (C vs. T: P = 0.707) in Anhui Chinese population (Table 1).
IFNG and TBX21 interaction with SLE susceptibility. Significant multiplicative interaction was 
detected between rs4794067 and rs2069705 in both codominant and dominant model. After adjusting for age and 
sex, this association was still statistically significant (Table 3). In contrast, significant interaction was not observed 
for rs4794067-rs2069718 combination. Because the numbers for some genotypes were small, and in most cases 
dominant models showed the better fit for association, we considered the dominant model in a further additive 
interaction analysis stage. The following analysis also identified a significant interaction (the relative excess risk 
due to interaction [RERI] = 0.66, 95% CI: 0.26–1.07) between rs4794067 and rs2069705 with controlling for age 
and sex. Similar to the finding of multiplicative interaction, additive interaction analysis between rs4794067 and 
rs2069718 showed no statistically significant association with SLE susceptibility (Table 3).
Discussion
Kim, et al. reported that rs2069705 in IFNG promoter was most significantly associated with SLE susceptibility 
in Korean subjects11. However, there are no replication studies indicating an association between IFNG gene and 
SLE in Chinese population. Our present study revealed that the rs2069705 was associated with SLE in Anhui 
Chinese Han population. It should be noted that the odds ratio and the significance level for rs2069705 is mar-
ginal (P = 0.046). Thus, this association may be false positive. To confirm this marginal effect, a meta-analysis by 
using four studies was conducted to produce a more comprehensive result. The data showed that the SNP was 
Gene SNP
Genotype SLE(1466) Controls(2266) HWE Cases versus controls
/Allele n (%) n (%) P exact OR (95% CI) P value
TBX21 rs4794067 TT 1118(0.76) 1732(0.76)
TC 314(0.21) 494(0.22)
CC 34(0.02) 40(0.02) 0.506 1.32(0.83–2.09)* 0.243
T 2550 (0.87) 3958(0.87)
C 382 (0.13) 574(0.13) 1.03(0.90–1.19) 0.647
IFNG rs2069705 CC 885(0.60) 1428(0.63)
TC 501(0.34) 742(0.33)
TT 80(0.05) 96(0.04) 1.000 1.35(0.99–1.83)# 0.059
C 2271(0.77) 3598(0.79)
T 661(0.23) 934(0.21) 1.12(1.00–1.26) 0.046
IFNG rs2069718 TT 1104(0.75) 1726(0.76)
TC 340(0.23) 500(0.22)
CC 22(0.02) 40(0.02) 0.572 0.86(0.51–1.46)* 0.573
T 2548(0.87) 3952(0.87)
C 384(0.13) 580(0.13) 1.03(0.89–1.18) 0.707
Table 1.  Genotype characteristics of each single nucleotide polymorphism. n, number; SNP, single 
nucleotide polymorphisms; OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg Equilibrium; SLE, 
systemic lupus erythematosus. *CC versus TT in cases versus controls. #TT versus CC in cases versus controls.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:22081 | DOI: 10.1038/srep22081
significantly associated with SLE susceptibility in Asians although stratification by race reveals this genetic asso-
ciation is found more in Korean than in Chinese population. These findings suggest that the SNP (rs2069705) in 
IFNG promoter may be a common variant in Asian populations, and thus might improve our understanding of 
the pathogenesis of SLE and provide new targets for therapeutic interventions. In contrast, our replication study 
suggests that rs4794067 in TBX21 promoter and rs2069718 in IFNG intron are not involved in SLE susceptibility 
in Chinese Han population. The heterogeneity was probably due to difference in sample size, genotyping method 
or source of controls10,11. Therefore, future researches are still required to confirm these findings and investigate 
other SNPs among these genes in different ancestries.
To test for possible gene–gene interactions, we performed an analysis using multiplicative and additive inter-
action scales. The identified interaction between TBX21 (rs4794067) and IFNG (rs2069705) may be biologic. 
Firstly, the transcription factor T-bet (TBX21) is the master regulator of Th1 immune response primarily by 
promoting expression of the IFNG. This functional link suggests both TBX21 and IFNG can participate in the 
same causal mechanism. Secondly, available data has suggests that the C allele rs4794067 in TBX21 promoter is 
a functional SNP and is associated with decreased T-bet expression levels8. Mechanism analysis further showed 
that the polymorphism is associated with decreased IFNG production by primary human lymphocytes from 
healthy participants9. Although the significantly associated SNP (rs2069705) in IFNG promoter has not been 
examined for its effects on IFNG expression levels, a SNP (rs2430561) in intron of IFNG has been reported to 
Groups/Comparisons
Test of association
Methods
Test of heterogeneity
OR (95% CI) P-value I2 P-value
A. Four studies
 T versus C 1.11(1.04–1.19) 0.002 M-H 0.0% 0.481
 TT + TC versus CC 1.11(1.02–1.21) 0.012 M-H 0.0% 0.716
 TT versus TC + CC 1.28(1.07–1.54) 0.008 M-H 52.8% 0.095
 TT versus CC 1.33(1.10–1.60) 0.003 M-H 49.4% 0.115
B. Three studies*
 T versus C 1.13(1.04–1.22) 0.004 M-H 9.5% 0.331
 TT + TC versus CC 1.11(1.01–1.22) 0.032 M-H 0.0% 0.515
 TT versus TC + CC 1.43(1.15–1.78) 0.002 M-H 41.8% 0.179
 TT versus CC 1.46(1.17–1.83) 0.001 M-H 45.2% 0.161
C. Two Chinese studies
 T versus C 1.10(1.01–1.21) 0.027 M-H 0.0% 0.678
 TT + TC versus CC 1.12(1.01–1.25) 0.037 M-H 0.0% 0.942
 TT versus TC + CC 1.16(0.93–1.45) 0.198 M-H 21.6% 0.259
 TT versus CC 1.21(0.96–1.52) 0.099 M-H 0.0% 0.322
D. Two Korean studies
 T versus C 1.13(1.01–1.26) 0.033 M-H 54.6% 0.138
 TT + TC versus CC 1.10(0.96–1.26) 0.161 M-H 22.9% 0.255
 TT versus TC + CC 1.59(1.15–2.20) 0.005 M-H 63.2% 0.099
 TT versus CC 1.66(0.93–2.99) 0.089 D-L 67.2% 0.081
Table 2.  Meta-analysis of the association between rs2069705 and SLE risk in Asian populations. OR, odds 
ratio; CI, confidence intervals; I2, I-square; M-H, Mantel–Haenszel; D-L, DerSimonian–Laird. *All the three 
studies were based on MassARRAY platform of Sequenom (without data from the Hong Kong GWAS).
SNP combinations Test model*
Multiplicative interaction Additive interaction
OR (95% CI) P value RERI (95% CI) AP (95% CI)
rs4794067- rs2069705 Codominant model 1.31(1.03–1.66)a 0.027
1.31(1.03–1.67)b 0.026
Dominant model 3.04(1.10–8.41)a 0.032 0.70(0.33–1.06)a 1.18(0.08–2.28)a
2.81(1.00–7.84)b 0.049 0.66(0.26–1.07)b 1.16(− 0.01–2.34)b
rs4794067- rs2069718 Codominant model 1.09(0.81–1.46)a 0.569
1.09(0.81–1.47)b 0.567
Dominant model 1.79(0.53–6.01)a 0.350 0.45(− 0.27–1.16)a 0.62(− 0.53–1.77)a
1.70(0.50–5.81)b 0.398 0.42(− 0.35–1.18)b 0.61(− 0.66–1.88)b
Table 3. Genetic interaction analysis between TBX21 and IFNG. SNP, single nucleotide polymorphisms; 
OR, odds ratio; CI, confidence intervals; RERI, the relative excess risk due to interaction; AP, the attributable 
proportion due to interaction. *The risk allele of rs4794067 and rs2069705 is T, the risk allele of rs2069718 is C. 
aGenetic interaction analysis without adjusting for age and sex. bGenetic interaction analysis with adjusting for 
age and sex.
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affect the IFNG expression level11,13,14. Thirdly, elevated expression levels of IFNG are involved in the pathogenesis 
of SLE in both human disease and murine models4,5. Therefore, such genetic interaction may imply that TBX21 
can act as a collaborator with IFNG to contribute to risk of SLE although the polymorphism in TBX21 alone does 
not increase susceptibility of the disease. However, further researches in this field are warranted to confirm this 
genetic interaction by using both statistical methods and functional studies.
In summary, our study identified a genetic variant in IFNG that is significantly associated with SLE risk in 
Chinese populations. We also provided evidence that gene–gene interaction between TBX21 and IFNG may 
jointly affect the susceptibility of SLE. These findings highlight Th1 cell response as an important contributor to 
the pathogenesis of SLE.
Materials and Methods
Patients and controls. Patients with SLE were recruited from the First Affiliated Hospital of Anhui Medical 
University and Anhui Provincial Hospital (Affiliated to Anhui Medical University). The diagnosis of SLE was 
based on the presence of the combination of at least four criteria of 1997 American College of Rheumatology 
(ACR) revised criteria for the classification of SLE15,16. The healthy controls were matched to the patients geo-
graphically and ethnically. Informed consent was obtained from all patients and healthy control subjects. The 
study was approved by the medical ethics committee of Anhui Medical University. Methods were carried out in 
accordance with the approved guidelines.
Genotyping. We genotyped rs2069705 in the IFNG promoter and rs2069718 in the IFNG intron, which were 
associated with risk of SLE in Korean population11. In addition, the functional SNP (rs4794067) in the TBX21 
promote was selected for the current study8–10. The genotyping was conducted using Sequenom Massarray system 
(Sequenom Inc., San Diego, CA, USA). The genotype success rates for the three SNPs were higher than 98%. Only 
those individuals with 100% genotype success for all markers were included for final analysis.
Data analysis. The genotype frequencies of the SNPs were tested for Hardy-Weinberg equilibrium in control 
subjects. Disease associations were analyzed by chi-square test. It should be noted that a total of 22 SNPs were 
genotyped by the Sequenom Massarray system at the same time. These genotyped SNPs can be mapped into 
multiple signaling pathways, but only the 3 SNPs (rs2069705, rs2069718 and rs4794067) are directly involved 
in immune response of Th1 cells. Although prior data have shown that genetic variants in TBX21 and IFNG are 
connected with risk of SLE in Asians10–12. For multiple-testing correction, bonferroni adjustment was still applied 
and the statistical significance level was set at α = 0.0023 (0.05/22). Association was considered significant for 
P < 0.0023 but marginal when 0.0023 ≤ P ≤ 0.05.
The multiplicative gene-gene interactions were estimated using multiple logistic regression models. For each 
individual, key variables were defined as a binary variable indicating case–control status, with SNP variables rang-
ing from 0 to 2 indicating the number of risk alleles in an individual subject (codominant model). Additionally, 
dominant model were also tested. For each SNP pair, a logistic regression model was built to predict case–control 
status (dependent variable) based on the indicator variables (sex and age) and the 2 SNP variables (independent 
variable), for a total of 4 variables and an intercept2,17.
For meta-analysis, genotyped data of rs2069705 in three independent studies was available. These data sources 
included the Anhui study, two Korean studies by Kim, et al.11,12. For archiving a lager statistical power, genotyped 
information of the SNP from Hong Kong GWAS was extracted (the data was provided by Dr. Wanling Yang, 
University of Hong Kong) for the pooled analysis18. The genotype distribution of rs2069705 in cases from Hong 
Kong GWAS for CC/TC/TT is 308/249/49, and in controls is 1166/826/174. The pooled estimate of OR and P 
value were obtained by a random-effects (DerSimonian–Laird) or a fixed-effects model (Mantel–Haenszel) in the 
presence or absence of heterogeneity, respectively. The heterogeneity was assessed by Cochrane’s Q test and the 
I-square statistic19,20. In this study, the combined effect sizes were calculated by fixed-effects meta-analysis when 
p values in Q-statistic ≥ 0.095.
The attributable proportion due to interaction (AP) and RERI were used to test additive gene-gene inter-
actions. If there is no biologic interaction, RERI and AP are equal to 0 2,17. A detailed calculation method of 
additive interaction including definition of two indicator variables, an STATA program, and a calculator in Excel 
(available at http://www.epinet.se) was described by Andersson, et al.21. The STATA program delivered estimates 
of the required parameters together with the covariance matrix, which are used in calculation of the interaction 
measures in the Excel calculator. The confounding factors including sex and age were controlled for additive 
interaction analysis.
Statistical analysis was performed using SPSS13.0 software (SPSS Inc., Chicago, IL, USA) and Stata version 
12.0 (Stata Corp, College Station, TX, USA). 
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